Peanuts for Cardiometabolic, Brain, and Intestinal Health
NCT06867198
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The overall objective of this 14-month randomized crossover study is to seek evidence demonstrating that daily consumption of peanuts and peanut products improve cardiometabolic, cognitive, and intestinal health in a racially diverse prediabetes population.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Prediabetes
- Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
- Cognition
- Microvascular Function
- Gut Microbiota
- Endothelial Function (Reactive Hyperemia)
- Arterial Stiffness, Blood Pressure
- Adult
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 20 to 59 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Georgia State University
- Last updated on ClinicalTrials.gov
- September 2, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Georgia · 1
- Georgia State University · Atlanta, GA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.